SPECTRO GLIO trial aftermath: Where do we go from here?
Neuro Oncol
.
2024 Jan 5;26(1):164-165.
doi: 10.1093/neuonc/noad166.
Authors
Hui-Kuo G Shu
1
2
,
Hyunsuk Shim
1
3
4
2
Affiliations
1
Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia, USA.
2
Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia, USA.
3
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia, USA.
4
Department of Biomedical Engineering, Emory University School of Medicine, Atlanta, Georgia, USA.
PMID:
37675932
PMCID:
PMC10768972
DOI:
10.1093/neuonc/noad166
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Glioblastoma*
Humans
Grants and funding
U01 CA264039/CA/NCI NIH HHS/United States
R01 CA214557/CA/NCI NIH HHS/United States